Roots Corp T.ROOT

Alternate Symbol(s): RROTF

Consumer Cyclical Apparel Stores

Roots Corporation is a global lifestyle brand company. The Company designs, markets, and sells a range of selection of products in different departments, including women's men's, children's, and gender-free apparel, leather goods, footwear, and accessories. It operates through two segments: Direct-to-Consumer and Partners and Other. The Direct-to-Consumer segment comprises of sales through corporate retail stores and the Company's e-commerce Website www.roots.com. The Partners and Other segment consist primarily of the wholesale of Roots-branded products to its international operating partner. The Partners and Other segment also include the Company's sales from its Roots-branded storefront on business-to-consumer marketplace Website Tmall.com in China, the wholesale of Roots-branded products to select retail partners, and the sale of custom Roots-branded products to select business clients. It operates over 100 corporate retail stores in Canada and two stores in the United States.

TSX:ROOT - Post by User

Roots Corp

<< Previous

Bullboard Posts

Next >>

Post by Chefboy69on Apr 07, 2022 9:14am

217 Views

Post# 34583668

great financials

Fiscal 2021 Financial Highlights

Total sales of $273.8 million, up 13.9% from $240.5 million in F2020.

Direct-to-Consumer ("DTC") sales of $235.8 million, up 13.3% from $208.2 million in F2020.

Gross margin of 59.5%, as compared to 58.1% in F2020 and 53.4% in F2019.

DTC gross margin of 62.6%, up 150 basis points ("bps") from 61.1% in F2020, and up 640 bps from 56.2% in F2019.

Selling, general and administrative expenses of $122.9 million, up from $114.8 million in F2020.

Adjusted EBITDA of $50.1 million, a 29.4% increase from $38.7 million in F2020, and a 92.3% increase from $26.1 million in F2019. See "Non-IFRS Measures and Industry Metrics".

Net income of $22.8 million ($0.54 per share), up from $13.1 million ($0.31 per share) in F2020.

Adjusted Net Income of $27.5 million ($0.65 per share), up from $16.5 million ($0.39 per share) in F2020. See "Non-IFRS Measures and Industry Metrics".

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks